The current valuation score of Ironwood Pharmaceuticals Inc is 8.82, ranking 66 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 5.63, which is 14617.45% below the recent high of 828.21 and 11946.80% above the recent low of -666.67.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.